• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

Predicting microbial interactions in the human gut

March 4, 2021 Microbiome Times

The human gut consists of a complex community of microbes that consume and secrete hundreds of small molecules–a phenomenon called cross-feeding. However, it is challenging to study these processes experimentally. A new study, published in […]

Finance

Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health

February 19, 2021 Microbiome Times

Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age […]

Pharma & Human Health

Smectite promotes probiotic biofilm formation in gut for cancer immunotherapy

February 15, 2021 Microbiome Times

Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice. The paper entitled “Smectite […]

Finance

Global biotech executive to boost microbiome drug development for Asia Pacific

February 11, 2021 Microbiome Times

Global biotech executive Thomas Mitchell is set to drive growth, innovation and expansion across Asia Pacific for thriving biotechnology start-up BiomeBank, Australia’s first public stool bank and microbiome therapeutics company, bringing with him a wealth […]

Editor's Choice

Fecal transplant turns cancer immunotherapy non-responders into responders

February 10, 2021 Microbiome Times

Fecal transplant changes the gut microbiome, turning cancer immunotherapy non-responders into responders. Video Credits: UNIVERSITY OF PITTSBURGH   Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut […]

Pharma & Human Health

Investigating the removal of dry biofilm with probiotic cleansers

February 9, 2021 Microbiome Times

A CONCEPT known as dry biofilms has emerged over the past few years and they have shown to frequently harbour potentially infectious organisms, just like the ones present in Hospital Acquired Infections (HAIs). However, as […]

Pharma & Human Health

MIND and Mediterranean diets associated with later onset of Parkinson’s disease

February 5, 2021 Microbiome Times

A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson’s disease (PD). While researchers have long known of neuroprotective effects of the MIND […]

Pharma & Human Health

Lactobacillus manipulates bile acids to create favorable gut environment

February 4, 2021 Microbiome Times

New research from North Carolina State University reveals that probiotic Lactobacillus bacteria use enzymes situationally to manipulate bile acids and promote their own survival in the gut. These findings further elucidate the complicated relationship between […]

Pharma & Human Health

Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate Phase 3 Clinical Trial Evaluating Microbiome Protector DAV132

February 3, 2021 Microbiome Times

Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to prevent the life-threatening effects antibiotics have on the gut microbiome of cancer patients, announced today that it received approval to start enrolling patients in a […]

Pharma & Human Health

Study suggests that gut fungi are not associated with Parkinson’s disease

February 1, 2021 Microbiome Times

The bacterial gut microbiome is strongly associated with Parkinson’s disease (PD), but no studies had previously investigated he role of fungi in the gut. In this novel study published in the Journal of Parkinson’s Disease, […]

Editor's Choice

Why microbiota samples should be collected in all clinical trials?

January 26, 2021 Isabelle de Cremoux

In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing interest towards our microbiome research-focused Health for Life […]

Posts navigation

« 1 … 41 42 43 … 86 »

QIAGEN’S NEW HIGH-THROUGHPUT BENCHTOP AUTOMATION SYSTEM

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
sign up

Sign up to the Microbiome Times newsletter